InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,181.60
(
-0.43%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
84.85
(
0.00%
)
Bitcoin
61,604.97
(
1.17%
)
Post# of 252434
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: mcbio post# 148200

Wednesday, 09/05/2012 10:07:11 AM

Wednesday, September 05, 2012 10:07:11 AM

Post# of 252434
I find the fact that there are several compounds (peptide/nonpeptide antagonists, RNAi, or anti-CXCR4 mAb*) targeted to block the SDF-1/CXCR4 complex in clinical trials good for BLRX in the sense of validating the MOA.

http://www.ncbi.nlm.nih.gov/pubmed/22376154

* BMS-936564 isn't mentioned in the abs.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up